相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Matthew R. Gardner et al.
NATURE (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
The potential of adeno-associated viral vectors for gene delivery to muscle tissue
Dan Wang et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Role of Fc-mediated antibody function in protective immunity against HIV-1
George K. Lewis
IMMUNOLOGY (2014)
Vaccination with gag, vif, and nef Gene Fragments Affords Partial Control of Viral Replication after Mucosal Challenge with SIVmac239
Mauricio A. Martins et al.
JOURNAL OF VIROLOGY (2014)
Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques
C. Moog et al.
MUCOSAL IMMUNOLOGY (2014)
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
Mario Roederer et al.
NATURE (2014)
Adeno-associated virus delivery of broadly neutralizing antibodies
Bruce C. Schnepp et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
D. Gaudet et al.
GENE THERAPY (2013)
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Margaret E. Ackerman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A largely random AAV integration profile after LPLD gene therapy
Christine Kaeppel et al.
NATURE MEDICINE (2013)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A. Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
New paradigms for functional HIV-specific nonneutralizing antibodies
Don Forthal et al.
CURRENT OPINION IN HIV AND AIDS (2013)
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
Peter D. Kwong et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Emerging Concepts on the Role of Innate Immunity in the Prevention and Control of HIV Infection
Margaret E. Ackerman et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer
George Buchlis et al.
BLOOD (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1-or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays
Michael D. Alpert et al.
JOURNAL OF VIROLOGY (2012)
A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques
Brian Moldt et al.
JOURNAL OF VIROLOGY (2012)
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Dawn E. Bowles et al.
MOLECULAR THERAPY (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Florian Klein et al.
NATURE (2012)
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
Dennis R. Burton et al.
SCIENCE (2012)
ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge
Michael D. Alpert et al.
PLOS PATHOGENS (2012)
Assessing the potential for AAV vector genotoxicity in a murine model
Hojun Li et al.
BLOOD (2011)
Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus
John P. Bilello et al.
JOURNAL OF VIROLOGY (2011)
A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fcγ Receptors To Define the Role of Effector Functions in Protection against HIV
Brian Moldt et al.
JOURNAL OF VIROLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen et al.
NATURE (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal et al.
SCIENCE (2011)
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
Norman L. Letvin et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines
Ruth H. Florese et al.
JOURNAL OF IMMUNOLOGY (2009)
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
Philip R. Johnson et al.
NATURE MEDICINE (2009)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
Bin Jia et al.
PLOS PATHOGENS (2009)
Gene Therapy Using Adeno-Associated Virus Vectors
Shyam Daya et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Self-complementary AAV vectors; Advances and applications
Douglas M. McCarty
MOLECULAR THERAPY (2008)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality
Bernard J. Scallon et al.
MOLECULAR IMMUNOLOGY (2007)
Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus
Amitinder Kaur et al.
VIROLOGY (2007)
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
Nancy A. Wilson et al.
JOURNAL OF VIROLOGY (2006)
High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes
Guang-Ping Gao et al.
JOURNAL OF VIROLOGY (2006)
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)
B Joos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro et al.
JOURNAL OF VIROLOGY (2005)
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
A Trkola et al.
NATURE MEDICINE (2005)
Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239
DT Evans et al.
JOURNAL OF VIROLOGY (2005)
Stable antibody expression at therapeutic levels using the 2A peptide
JM Fang et al.
NATURE BIOTECHNOLOGY (2005)
Long-term pharmacologically regulated expression of erythropoietin in,primates following AAV-mediated gene transfer
VM Rivera et al.
BLOOD (2005)
Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251
VR Gómez-Román et al.
JOURNAL OF IMMUNOLOGY (2005)
Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities
WE Johnson et al.
JOURNAL OF VIROLOGY (2003)
Genetic fate of recombinant adeno-associated virus vector genomes in muscle
BC Schnepp et al.
JOURNAL OF VIROLOGY (2003)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer
AD Lewis et al.
JOURNAL OF VIROLOGY (2002)
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239
H Horton et al.
JOURNAL OF VIROLOGY (2002)
Role of CD8+ lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
JD Lifson et al.
JOURNAL OF VIROLOGY (2001)
Immune evasion strategies of the primate lentiviruses
DT Evans et al.
IMMUNOLOGICAL REVIEWS (2001)
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus
CG Murphy et al.
JOURNAL OF VIROLOGY (2000)
分享论文
